Blood carnitine status after orthotopic liver transplantation in patients with end-stage liver disease
GLP-1 receptor agonists are medications that imitate the effects of glucagon-like peptide-1, a hormone released after eating
Same-day virtual appointments and physician-guided GLP-1 weight-loss care from home
5 In addition to approved indications, GLP-1 agonists may have a role in the management of cutaneous disease, as demonstrated through off-label treatment in the literature (Table 1)
Thus, the affordability, accessibility, and efficacy of these drugs have led financial analysts to predict that the GLP-1RA market will exceed $100 billion by 2030
This treatment has been proven to help reduce body fat, particularly visceral fat, which is associated with various health risks such as heart disease, diabetes, and hypertension